Skip to content
Trial Eligibility
Menu

ED90 of Epidural Bupivacaine With Lidocaine for the Initiation of Labor Analgesia

NCT05543694

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

To estimate the dose of bupivacaine required to achieve initial effective comfort in 90% of patients (ED90) via the epidural (DPE or EPL) technique in women undergoing labor after receiving a lidocaine "test dose"

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Labor Pain
  • Analgesia

Eligibility basics and study details

Study type
Interventional
Phase
Phase 4
Ages
18 to 50 years
Sex
Female
Healthy volunteers
Accepted
Sponsor
Brigham and Women's Hospital
Last updated on ClinicalTrials.gov
July 13, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Massachusetts · 1

  • Brigham and Women's Hospital · Boston, MA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.